Avid Bioservices’ stockholders approve transaction with GHO and Ampersand

Avid Bioservices (CDMO) announced that Avid stockholders voted to approve the transaction with GHO Capital Partners and Ampersand Capital Partners at the Avid special meeting of stockholders held earlier today. “We thank our stockholders for their support through our time as a public company and the duration of this process,” said Nick Green, president and CEO of Avid Bioservices. “We look forward to completing the transaction and delivering significant, immediate and certain cash value to our stockholders.” With today’s stockholder approval, all closing conditions, other than those to be satisfied at closing, have been met and regulatory approvals have been received, and the Company therefore expects the transaction to close in the coming days. The final, certified voting results for the Special Meeting will be provided in a Form 8-K filed with the U.S. Securities and Exchange Commission.